Ectopic Osteogenesis by Ex Vivo Gene Therapy Using Beta Tricalcium Phosphate as a Carrier

REFERENCES

• Steffen T., Marchesi D., Aebi M. Posterolateral and anterior interbody spinal fusion models in the sheep. Clin. Orthop. 2000; 371: 28–37
   PubMedGoogle Scholar
• Metsger D.S., Dephilip R.M., Hayes T.G. An autoradiographic study of calcium phosphate ceramic bone implants in turkeys. Clin. Orthop. Relat. Res. 1993; 291: 283–294
   PubMedGoogle Scholar
• Bensaïd W., Oudina K., Viateau V., Potier E., Bousson V., Blanchat C., Sedel L., et al. De novo reconstruction of functional bone by tissue engineering in the metatarsal sheep model. Tissue Eng. 2005; 11(5–6)814–824
   PubMedGoogle Scholar
• Urist M.R., Lietze A., Dawson E. b-tricalcium phosphate delivery system for bone morphogenetic protein. Clin Orthop. 1984; 187: 277–280
   PubMed Web of Science ®Google Scholar
• Ogose A., Hotta T., Hatano H., Kawashima H., Tokunaga K., Endo N., Umezu H. Histological examination of beta-tricalcium phosphate graft in human femur. J. Biomed. Mater. Res. 2002; 63: 601–604
   Google Scholar
• Jingushi S., Urabe K., Okazaki K., Hirata G., Sakai A., Ikenoue T., Iwamoto Y. Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with beta-tricalcium phosphate as a carrier: in vivo bone banking for muscle-pedicle autograft. J. Orthop. Sci. 2002; 7: 490–494
   PubMedGoogle Scholar
• Alam I., Asahina I., Ohmamiuda K., Enomoto S. Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes. J. Biomed. Mater. Res. 2001; 54: 129–138
   PubMed Web of Science ®Google Scholar
• Laffargue P., Hildebrand H.F., Rtaimate M., Frayssinet P., Amoureux J.P., Marchandise X. Evaluation of human recombinant bone morphogenetic protein-2-loaded tricalcium phosphate implants in rabbits’ bone defects. Bone 1999; 25(suppl)55S–58S
   PubMedGoogle Scholar
• Urist M.R., Nilsson O., Rasmussen J., Hirota W., Lovell T., Schmalzreid T., Finerman G.A. Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate(TCP) composite in skull trephine defects in dogs. Clin. Orthop. 1987; 214: 295–304
   PubMedGoogle Scholar
• Bruder S.P., Jaiswal N., Ricalton N.S., Mosca J.D., Kraus K.H., Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin. Orthop. Relat. Res. 1998; 355 suppl: S247–S256
   PubMedGoogle Scholar
• Chang S.C., Chuang H., Chen Y.R., Yang L.C., Chen J.K., Mardini S., Chung H.Y., et al. Cranial repair using BMP-2 gene engineered bone marrow stromal cells. J. Surg. Res. 2004; 119(1)85–91
   PubMed Web of Science ®Google Scholar
• Tsuda H., Wada T., Ito Y., Uchida H., Dehari H., Nakamura K., Sasaki K., et al. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol. Ther. 2003; 7(3)354–365
   PubMed Web of Science ®Google Scholar
• Blum J.S., Barry M.A., Mikos A.G., Jansen J.A. In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model. Hum. Gene. Ther. 2003; 14(18)1689–1701
   PubMed Web of Science ®Google Scholar
• Dai K.R., Xu X.L., Tang T.T., Zhu Z.A., Yu C.F., Xu M., Zhu L.L., et al. BMP-2 gene modified tissue-engineered bone repairing segmental tibial bone defects in goats. Zhonghua Yi Xue Za Zhi 2003; 83(15)1345–1349
   PubMedGoogle Scholar
• Cheng S.L., Lou J., Wright N.M., Lai C.F., Avioli L.V., Riew K.D. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carry the human BMP-2 gene. Calcif. Tis. Int. 2001; 68(2)87–94
   PubMed Web of Science ®Google Scholar
• Lou J., Xu F., Merkel K., Manske P. Gene therapy: adenovirusmediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell differentiation ex vivo, bone formation in vivo. J. Orthop. Res. 1999; 17: 43–50
   PubMed Web of Science ®Google Scholar
• Alden T.D., Varady P., Kallmes D.F., Jane J.A., Jr., Helm G.A. Bone morphogenetic protein gene therapy. Spine 2002; 27(16S)S87–S93
   PubMedGoogle Scholar
• Rodan G.A., Rodan S.B. Expression of the osteoblastic phenotype. Bone and Mineral Research, W.A. Peck. Elsevier Science, Amsterdam 1984; 2: 244–285
   Google Scholar
• Sodek J., Cheifitz S. Molecular regulation of osteogenesis. Bone Engineering, em squared Inc., J.E. Davies. em squared Inc., Toronto 2000; 31–285
   Google Scholar
• Owen T.A., Aronow M., Shalhoub V., Barone L.M., Wilming L., Tassinari M.S., Kennedy M.B., et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 1990; 143: 420–430
   PubMed Web of Science ®Google Scholar
• Aubin J.E. Advances in the osteoblast lineage. Biochem. Cell Biol. 1998; 76: 899–910, review
   PubMed Web of Science ®Google Scholar
• Aubin J.E. Osteogenic cell differentiation. Bone engineering, J.E. Davies. em squared Inc., Toronto 2000; 19–30
   Google Scholar
• Fisher L.W., Termine J.D. Noncollagenous proteins influencing the local mechanisms of calcification. Clin Orthop. 1985; 200: 362–385
   PubMed Web of Science ®Google Scholar
• Sodek J., Zhang Q., Goldberg H.A., Domenicucci C., Kasugai S., Wrana J.L., Shapiro H., Chen J. Non-collagenous bone proteins and their role in substrate-induced bioactivity. The Bone–Biomaterial Interface, J.E. Davies. (University of Toronto Press, Toronto) 1991; 97–110
   Google Scholar
• Moss D.W. Perspectives in alkaline phosphatase research. Clin Chem. 1992; 38: 2486–2492
   PubMed Web of Science ®Google Scholar
• Glimcher M.J. The role of collagen and phosphoproteins in the calcification of bone and other collagenous tissues. Calcium in biological systems, R.P. Rubin, G. Weiss, J.W. Putney, Jr. Plenum, New York 1985; 607–616
   Google Scholar
• Roach H.I. Why does bone matrix contain noncollagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin and bone sialoprotein in bone mineralization and resorption. Cell Biol. Int. 1994; 18: 617–628
   PubMed Web of Science ®Google Scholar
• Genovese C., Rowe D., Kream B. Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry 1984; 23: 6210–6216
   PubMed Web of Science ®Google Scholar
• Cowles E.A., DeRome M.E., Pastizzo G., Brailey L.L., Gronowicz G.A. Mineralization and the expression of matrix proteins during in vivo bone development. Calcif Tissue Int. 1998; 62: 74–82
   PubMed Web of Science ®Google Scholar
• Milani S., Herbst H., Schuppan D., Surrenti C., Riecken E.O., Stein H. Cellular localization of type I III and IV procollagen gene transcripts in normal and fibrotic human liver. Am. J. Pathol. 1990; 137: 59–70
   PubMed Web of Science ®Google Scholar
• Delany A.M., Kalajzic I., Bradshaw A.D., Sage E.H., Canalis E. Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. Endocrinology 2003; 144: 2588–2596
   PubMed Web of Science ®Google Scholar
• Termine J.D., Kleinman H.K., Whitson S.W., Conn K.M., McGarvey M.L., Martin G.R. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981; 26: 99–105
   PubMed Web of Science ®Google Scholar
• Jundt G., Berghauser K.H., Termine J.D., Schulz A. Osteonectin-a differentiation marker of bone cells. Cell Tissue Res 1987; 248(2)409–415
   PubMed Web of Science ®Google Scholar
• Yoon K., Buenaga R., Rodan G.A. Tissue specificity and developmental expression of rat osteopontin. Biochem. Biophys. Res. Commun. 1987; 148(3)1129–1136
   PubMed Web of Science ®Google Scholar